16th Annual Indy Hematology Review

16th Annual Indy Hematology Review is organized by Indy Hematology Education, Inc and will be held on Mar 09, 2019 at JW Marriott Indianapolis, Indianapolis, Indiana, United States of America.

Accreditation: 
CME Accreditation Statement :  Purdue University College of Pharmacy designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. 
CNE Accreditation Statement: This program is approved for 8.0 contact hours.
CPE Accreditation Statement: This program is approved for 8.0 contact hours (0.8 CEU’s).

Course Description:
This annual hematology review is one of the most comprehensive, educational hematology conferences in the country. Our exceptional faculty will provide a concise and practical summary of the American Society of Hematology annual meeting, presenting the most current hematology research and clinical practice.

Learning Objectives:
At the completion of this activity participants should be able to:
• Discuss new emerging hematology therapies in general and for chronic Myeloid Leukemia, acute Promylelocytic and Myeloid Leukemia, and Myeloproliferative neoplasms.
• Evaluate molecular diagnosis, targeted therapies, and resistance mechanisms of Waldenström’s Macroglobulinemia to assist in disease recognition.
• Discuss the advancement of immune check point inhibitors within hematologic malignancies and updated treatment paradigms presented at the American Society of Hematology meeting in San Diego, CA in December 2018.
• Recommend new regimens for Hematopoietic Stem Cell transplantation and identification of transplant candidates.
• Review the advancement in benign hematology research.
• Review new treatment regimens in follicular lymphoma.

Additional details will be posted as soon as they are available.